Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Celsentri

CELSENTRI 150 mg film-coated tablets CELSENTRI 300 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 15

HOS-118480 · Präparat HOS-094825

System Organ Class Adverse reaction Frequency Infections and infestations Pneumonia, oesophageal candidiasis uncommon Neoplasm benign, malignant and Bile duct cancer, diffuse large B-cell rare unspecified (including cysts and lymphoma, Hodgkin’s disease, polyps) metastases to bone, metastases to liver, metastases to peritoneum, nasopharyngeal cancer, oesophageal carcinoma Blood and lymphatic system Anaemia common disorders Pancytopenia, granulocytopenia rare Metabolism and nutrition disorders Anorexia common Psychiatric disorders Depression, insomnia common Nervous system disorders Seizures and seizure disorders uncommon Cardiac disorders Angina pectoris rare Vascular disorders Postural hypotension (see section 4.4) uncommon Gastrointestinal disorders Abdominal pain, flatulence, nausea common Hepatobiliary disorders Alanine aminotransferase increased, common aspartate aminotransferase increased Hyperbilirubinaemia, gamma- uncommon glutamyltransferase increased Hepatitis toxic, hepatic failure, rare hepatic cirrhosis, blood alkaline phosphatase increased Hepatic failure with allergic features very rare Skin and subcutaneous tissue Rash common disorders Stevens-Johnson syndrome / Toxic rare / not known epidermal necrolysis Musculoskeletal and connective Myositis, blood creatine uncommon tissue disorders phosphokinase increased Muscle atrophy rare Renal and urinary disorders Renal failure, proteinuria uncommon General disorders and Asthenia common administration site conditions

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.